Research News for May 2009
1–7 of 7 articles
-
New Type of Targeted Therapy May Help Treat Triple-Negative Disease
Experimental targeted therapy medicines -- called PARP inhibitors -- may make chemotherapy work better against aggressive forms of breast cancer and also may be able to treat breast cancer alone, without chemotherapy.
-
Do Antidepressants Interfere with Tamoxifen? Results Unclear
While the results aren't definitive, one of two new studies suggests that women who take tamoxifen at the same time as the antidepressant medicines Prozac or Paxil may not get the full benefits of tamoxifen.
-
American Society Clinical Oncology Now Recommends Evista or Tamoxifen to Reduce Risk in High-Risk Women
New guidelines from the American Society of Clinical Oncology (ASCO) now recommend both tamoxifen and Evista (chemical name: raloxifene) to reduce breast cancer risk in post-menopausal women at high risk.
-
Certain Risk Factors Affect Different Types of Breast Cancer in Different Ways
A new study found that certain risk factors for breast cancer affect the risk of specific types of breast cancer in different ways.
-
Adding Taxotere to Standard Chemo Doesn’t Seem to Help Treat Early-Stage Breast Cancer
Taxotere doesn't seem to offer any benefits in treating early-stage breast cancer and also causes more serious side effects.
-
Older Women Do Better on Conventional Chemo Compared to Xeloda
Research shows that women older than 65 do better on standard intravenous chemotherapy after surgery to remove early-stage breast cancer than Xeloda (chemical name: capecitabine), an oral chemotherapy.
-
Molecular Test During Surgery May Help Find Cancer in Lymph Nodes
A test that quickly detects cancer cells in a lymph node during surgery to remove breast cancer is accurate enough to help doctors decide if lymph nodes need to be removed during the surgery.
1–7 of 7 articles
